US 8,008,338 B2Granted

Ketorolac tromethamine compositions for treating or preventing ocular pain

AssigneeAllergan, Inc.

InventorsChristopher A. Muller, Janet K. Cheetham, Teresa H. Kuan, David F. Power

Life of this patent

Estimating the term…

Abstract

Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.

Claims9

Dependent claims

An aqueous topical ophthalmic composition comprising 0.4% ketorolac.

Dependencies are inferred from the claim text.

Facts

Application: 10/856,192Filed 28 May 2004 · us provisional application
Priority: 3 Jun 2003
Published: US 2004/0248962 A19 Dec 2004
Granted: 30 Aug 2011
Term ends: Not estimatedThe source records don’t support an estimate.

Classification14 codes

A61K 31/407
Having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil: condensed with other…
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears
A61K 47/02
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents…:…
A61K 47/10
Containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides: alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene…

Family

Application60/475,683Us provisional application · filed 3 Jun 2003
US 2004/0248962 A1Pre-grant publication · published 9 Dec 2004
US 8,008,338 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results